Artichoke Leaf Extract: The Definitive Guide

What is artichoke leaf extract?

Artichoke leaf extract comes from the leaves of Cynara cardunculus L., also called Cynara scolymus. It differs from eating the flower head. Products vary by solvent, drug-to-extract ratio, total extract mass and standardization to caffeoylquinic acids, luteolin derivatives or other markers.

That variation limits dose transfer. “500 mg artichoke” is incomplete unless the plant part and extract concentration are known.

Typical Artichoke Leaf Extract Protocols

No RDA, AI or UL exists. Preserve the drug-to-extract ratio rather than treating all milligram labels as equivalent.

Plant identity

Record Cynara cardunculus or synonym Cynara scolymus and confirm leaf as the plant part.

Extract identity

Keep solvent, drug-to-extract ratio, extract mass and standardization together.

Administration

Record amount per administration and frequency; Holtmann used 640 mg three times daily.

Endpoint

Separate symptom scores, lipid biomarkers and liver enzymes.

What is artichoke leaf extract commonly used for?

Common goals include upper-abdominal fullness, bloating, functional dyspepsia, cholesterol and “liver support.” Human evidence is clearest for a specific extract in dyspepsia and for short-term biomarker changes. It does not establish treatment of gallbladder disease, bile-duct obstruction, cardiovascular events or progressive liver disease.

Which forms and labels matter?

Look for leaf, Latin name, extraction solvent, drug-to-extract ratio, extract per capsule, standardization, daily serving, lot and independent testing. Juice, food, whole powder and a concentrated dry extract should remain separate records.

What does the human evidence show?

Holtmann randomized 247 people with functional dyspepsia to placebo or two 320 mg extract tablets three times daily. Over six weeks, overall symptom improvement and disease-specific quality of life favored extract. The study supports that product and schedule; it does not establish a class effect for every artichoke supplement. [1]

Sahebkar pooled nine randomized trials with 702 participants. Total cholesterol fell 17.6 mg/dL, LDL 14.9 mg/dL and triglycerides 9.2 mg/dL relative to control; HDL did not significantly change. These are biomarkers from varied extracts and do not show fewer cardiovascular events. [2]

Amini pooled seven randomized trials and found lower ALT and AST. Heterogeneity and surrogate outcomes limit interpretation: an enzyme change does not prove reversal of steatosis, fibrosis or clinical liver disease. [3]

How might it work?

Proposed mechanisms include effects on bile secretion, digestive smooth muscle, cholesterol synthesis and oxidative or inflammatory pathways. These mechanisms do not establish clinical benefit and may also explain why bile-duct disorders require caution.

What are the risks and interactions?

EMA lists slight diarrhea with abdominal spasm, nausea, heartburn and allergic reactions. It says artichoke leaf medicines must not be used in certain liver and bile-duct disorders or with Asteraceae hypersensitivity. [4]

Severe or persistent upper-right abdominal pain, fever, jaundice, pale stool or dark urine needs assessment. Review use with medicines affecting glucose, blood pressure, lipids or anticoagulation; clinical interaction magnitudes are not well quantified. Pregnancy, breastfeeding and pediatric use remain inadequately studied.

Status in the United States and Canada

In the United States, extracts are sold as dietary supplements and are not approved to treat dyspepsia, dyslipidemia or liver disease. In Canada, licensed natural health products have product-specific conditions; an NPN does not establish equivalence to the trial extract.

What should be monitored?

Record product, lot, plant part, extraction ratio, amount per administration, timing relative to meals, symptoms, adverse effects, medicines and any clinician-directed laboratory dates.

What happens after stopping?

No withdrawal syndrome or taper is established. Recurrent or worsening digestive symptoms should prompt reassessment rather than indefinite dose escalation.

How should it be stored?

Follow the finished-product label, protect from heat and moisture, retain the lot and expiry date and keep out of children’s reach.

Community experiences

Anecdotes often omit the extract ratio and combine artichoke with ginger, bile salts or digestive enzymes. They cannot isolate which component changed symptoms.

How does it compare with other approaches?

Functional dyspepsia requires assessment for alarm features and cause-specific care. Prescribed lipid therapies have standardized doses and outcome evidence. Liver disease management targets its cause rather than relying on an enzyme change.

Frequently asked questions

What exact dose did the dyspepsia trial use?

Two 320 mg extract tablets three times daily, totaling 1,920 mg/day, for six weeks. [1]

Is eating artichoke equivalent?

No. Food and concentrated leaf extract differ in plant part, concentration and exposure.

Does it lower LDL?

The 2018 meta-analysis found a modest pooled LDL reduction, but trials varied and did not test cardiovascular events. [2]

Does lower ALT prove liver repair?

No. ALT is a biomarker and cannot alone establish histologic or clinical recovery.

Who should avoid it?

EMA identifies certain liver or bile-duct disorders and Asteraceae allergy as contraindications. [4]

Can it treat SIBO?

The cited evidence does not establish treatment of small-intestinal bacterial overgrowth.

Glossary

Terms used in this guide.

Artichoke leaf

The medicinal leaf material of Cynara cardunculus, synonymous with Cynara scolymus.

Drug-to-extract ratio

Amount of starting plant material used to produce a stated amount of extract.

Functional dyspepsia

Persistent upper-digestive symptoms without a structural explanation after appropriate evaluation.

LDL cholesterol

A lipid biomarker used in cardiovascular-risk assessment.

ALT

A liver-associated blood enzyme and surrogate biomarker.

Asteraceae

Plant family that includes artichoke, ragweed and daisies.

How this guide was researched

This draft uses one source-specific dyspepsia trial, separate pooled lipid and liver-enzyme evidence, and the current EMA botanical safety summary. Evidence checked October 9, 2026.

How this guide was made

The ledger preserves plant part, extract identity, per-administration amount, frequency, duration, population, endpoint and source access.

Sources

Related guides